咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎疗效分析

Treatment outcomes of medication therapy and balloon eustachian tuboplasty plus tympanostomy tube insertion for chronic secretory otitis media

目的:分析药物治疗和咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎临床疗效。方法:选取2019年11月~2023年3月弋矶山医院60例慢性分泌性中耳炎患者进行分组,观察组30例接受咽鼓管球囊扩张术+鼓膜置管术,对照组30例采用药物治疗,记录两组患者的纯音听阈均值(PTA)、气骨导差(ABG)以及咽鼓管功能障碍7项评分问卷(ETDQ-7)评分。结果:观察组术后总体有效率(100.00%)高于对照组(70.00%)(P<0.01)。观察组患者治疗前、治疗后1个月及治疗后3个月的PTA、ABG、ETDQ-7评分均较对照组患者下降(P<0.05)。结论:咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎安全有效,值得临床推广应用。

Objective:To compare the clinical efficacy of medication therapy and balloon eustachian tuboplasty plus tympanostomy tube insertion for chronic secretory otitis media.Methods:Sixty patients with chronic secretory otitis media treated in our hospital were included between November 2019 and March 2023 and divided into observational group and control group,in which patients received balloon eustachian tuboplasty(BET)plus tympanostomy tube insertion(TTI)and medication therapy respectively(both n=30).The pure tone audiometry(PTA),air-bone gap(ABG),and 7-item Eustachian Tube Dysfunction Questionnaire(ETDQ-7)scores were recorded in both groups.Results:The overall effective rate in the observational group was higher than that in the control group(100.00%vs.70.00%,P<0.01).The PTA,ABG and ETDQ-7 scores in both groups decreased sequentially before treatment,at 1 and 3 months after treatment(P<0.05).Conclusion:The clinical efficacy of BET plus TTI is favorable in the treatment of chronic secretory otitis media and it is worthy of clinical recommendation.